140 related articles for article (PubMed ID: 33294998)
1. Maternal cardiac function at 19-23 weeks' gestation in prediction of pre-eclampsia.
Gibbone E; Wright A; Vallenas Campos R; Sanchez Sierra A; Nicolaides KH; Charakida M
Ultrasound Obstet Gynecol; 2021 May; 57(5):739-747. PubMed ID: 33294998
[TBL] [Abstract][Full Text] [Related]
2. Screening for pre-eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation.
Sokratous N; Wright A; Syngelaki A; Kakouri E; Laich A; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Jan; 63(1):88-97. PubMed ID: 37724582
[TBL] [Abstract][Full Text] [Related]
3. Screening for pre-eclampsia by maternal serum glycosylated fibronectin at 11-13 weeks' gestation.
Sokratous N; Bednorz M; Sarli P; Morillo Montes OE; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):504-511. PubMed ID: 37401855
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic artery Doppler at 36 weeks' gestation in prediction of pre-eclampsia: validation and update of previous model.
Mansukhani T; Wright A; Arechvo A; Laich A; Iglesias M; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Feb; 63(2):230-236. PubMed ID: 37616530
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses.
Arechvo A; Wright A; Nobile Recalde A; Liandro R; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Mar; 63(3):358-364. PubMed ID: 37902727
[TBL] [Abstract][Full Text] [Related]
6. Maternal vascular indices at 36 weeks' gestation in the prediction of preeclampsia.
Mansukhani T; Wright A; Arechvo A; Lamanna B; Menezes M; Nicolaides KH; Charakida M
Am J Obstet Gynecol; 2024 Apr; 230(4):448.e1-448.e15. PubMed ID: 37778678
[TBL] [Abstract][Full Text] [Related]
7. Prediction of hypertensive disorders after screening at 36 weeks' gestation: comparison of angiogenic markers with competing-risks model.
Schiattarella A; Magee LA; Wright A; Syngelaki A; Akolekar R; Von Dadelszen P; Nicolaides KH
Ultrasound Obstet Gynecol; 2023 Sep; 62(3):345-352. PubMed ID: 37329494
[TBL] [Abstract][Full Text] [Related]
8. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
Cuenca-Gómez D; de Paco Matallana C; Rolle V; Valiño N; Revello R; Adiego B; Mendoza M; Molina FS; Carrillo MP; Delgado JL; Wright A; Santacruz B; Gil MM
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):522-530. PubMed ID: 37099759
[TBL] [Abstract][Full Text] [Related]
9. Pre-eclampsia screening in Denmark (PRESIDE): national validation study.
Riishede I; Rode L; Sperling L; Overgaard M; Ravn JD; Sandager P; Skov H; Wagner SR; Nørgaard P; Clausen TD; Jensen CAJ; Pihl K; Jørgensen FS; Munk JK; Zingenberg HJ; Pedersen NG; Andersen MR; Wright A; Wright D; Tabor A; Ekelund CK
Ultrasound Obstet Gynecol; 2023 Jun; 61(6):682-690. PubMed ID: 36840981
[TBL] [Abstract][Full Text] [Related]
10. Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.
Papastefanou I; Menenez M; Szczepkowska A; Gungil B; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 May; 63(5):613-618. PubMed ID: 38057964
[TBL] [Abstract][Full Text] [Related]
11. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).
Perales A; Delgado JL; de la Calle M; García-Hernández JA; Escudero AI; Campillos JM; Sarabia MD; Laíz B; Duque M; Navarro M; Calmarza P; Hund M; Álvarez FV;
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):373-382. PubMed ID: 27883242
[TBL] [Abstract][Full Text] [Related]
12. Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction.
Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
Ultrasound Obstet Gynecol; 2024 May; 63(5):635-643. PubMed ID: 37820083
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of angiogenic factors in prediction of growth-related neonatal morbidity at term and comparison with competing-risks model.
Papastefanou I; Nobile Recalde A; Silva Souza Y; Syngelaki A; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):457-465. PubMed ID: 37963283
[TBL] [Abstract][Full Text] [Related]
14. Validation of machine-learning model for first-trimester prediction of pre-eclampsia using cohort from PREVAL study.
Gil MM; Cuenca-Gómez D; Rolle V; Pertegal M; Díaz C; Revello R; Adiego B; Mendoza M; Molina FS; Santacruz B; Ansbacher-Feldman Z; Meiri H; Martin-Alonso R; Louzoun Y; De Paco Matallana C
Ultrasound Obstet Gynecol; 2024 Jan; 63(1):68-74. PubMed ID: 37698356
[TBL] [Abstract][Full Text] [Related]
15. Glycosylated fibronectin improves first-trimester prediction of pre-eclampsia.
Moungmaithong S; Wang X; Lau CSL; Tse AWT; Lee NMW; Leung HHY; Poon LC; Sahota DS
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):512-521. PubMed ID: 37616523
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of screening performance of first-trimester competing-risks prediction model for small-for-gestational age in Asian population.
Nguyen-Hoang L; Papastefanou I; Sahota DS; Pooh RK; Zheng M; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Yapan P; Sim WS; Poon LC;
Ultrasound Obstet Gynecol; 2024 Mar; 63(3):331-341. PubMed ID: 37552550
[TBL] [Abstract][Full Text] [Related]
17. Prediction using serum glycosylated fibronectin of imminent pre-eclampsia in women with new-onset hypertension.
Sokratous N; Bednorz M; Wright A; Nicolaides KH; Kametas NA
Ultrasound Obstet Gynecol; 2023 Nov; 62(5):653-659. PubMed ID: 37606310
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal assessment of angiogenic markers in prediction of adverse outcome in women with confirmed pre-eclampsia.
Binder J; Palmrich P; Kalafat E; Haberl C; Schirwani N; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2023 Dec; 62(6):843-851. PubMed ID: 37265117
[TBL] [Abstract][Full Text] [Related]
19. ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy.
Rolnik DL; Syngelaki A; O'Gorman N; Wright D; Poon LC; Nicolaides KH
Ultrasound Obstet Gynecol; 2023 Jun; 61(6):691-697. PubMed ID: 37058400
[TBL] [Abstract][Full Text] [Related]
20. Screening for pre-eclampsia with competing-risks model using placental growth factor measurement in blood samples collected before 11 weeks' gestation.
Riishede I; Ekelund CK; Sperling L; Overgaard M; Knudsen CS; Clausen TD; Pihl K; Zingenberg HJ; Wright A; Wright D; Tabor A; Rode L;
Ultrasound Obstet Gynecol; 2024 Mar; 63(3):342-349. PubMed ID: 37698230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
